Clinical Trials Directory

Trials / Completed

CompletedNCT01872338

Mindfulness-Based Cognitive Therapy for Suicide Prevention

Mindfulness-Based Cognitive Therapy for Preventing Suicide in Military Veterans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
135 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test a psychotherapeutic intervention that integrates cognitive therapy and mindfulness meditation techniques to prevent suicide in military Veterans.

Detailed description

Every month the VA becomes aware of approximately 1,100 Veterans in VA care who attempt suicide. While the VA has implemented a comprehensive, multifaceted suicide prevention approach, it has yet to implement nationally any evidence-based psychotherapies targeting suicide, a gap due largely to the dearth of evidence-based therapies for suicide. Primary aims of this proposal are to conduct a randomized controlled trial testing an adaptation of a cognitive-behavioral intervention, Mindfulness-Based Cognitive Therapy (MBCT), for Veterans on the VA's High Risk for Suicide List. The investigators' adapted version of MBCT for suicide (MBCT-S) integrates mindfulness meditation techniques with the VA Safety Plan to enhance patients' awareness of suicide triggers and appropriate coping strategies. This study has the potential to increase the range of cost effective treatment alternatives for the large number of suicidal Veterans for whom evidence-based therapies are severely limited.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness-Based Cognitive Therapy for SuicidePsychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
BEHAVIORALTreatment as usualVA standard care for suicide prevention

Timeline

Start date
2013-12-01
Primary completion
2019-04-03
Completion
2019-04-03
First posted
2013-06-07
Last updated
2020-05-05
Results posted
2020-04-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01872338. Inclusion in this directory is not an endorsement.